123 related articles for article (PubMed ID: 22345151)
1. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression.
Guo M; Liu W; Serra S; Asa SL; Ezzat S
Cancer Res; 2012 Apr; 72(8):2017-27. PubMed ID: 22345151
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
Naimi B; Latil A; Fournier G; Mangin P; Cussenot O; Berthon P
Prostate; 2002 Aug; 52(3):245-52. PubMed ID: 12111699
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
Zhu X; Lee K; Asa SL; Ezzat S
Am J Pathol; 2007 May; 170(5):1618-28. PubMed ID: 17456767
[TBL] [Abstract][Full Text] [Related]
4. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis.
Cha JY; Lambert QT; Reuther GW; Der CJ
Mol Cancer Res; 2008 Mar; 6(3):435-45. PubMed ID: 18337450
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia.
Zhu X; Asa SL; Ezzat S
Clin Cancer Res; 2008 Apr; 14(7):1984-96. PubMed ID: 18381936
[TBL] [Abstract][Full Text] [Related]
6. The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer.
Kondo T; Zhu X; Asa SL; Ezzat S
Clin Cancer Res; 2007 Aug; 13(16):4713-20. PubMed ID: 17699848
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
[TBL] [Abstract][Full Text] [Related]
8. Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells.
Moffa AB; Ethier SP
J Cell Physiol; 2007 Mar; 210(3):720-31. PubMed ID: 17133345
[TBL] [Abstract][Full Text] [Related]
9. Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer.
Ricol D; Cappellen D; El Marjou A; Gil-Diez-de-Medina S; Girault JM; Yoshida T; Ferry G; Tucker G; Poupon MF; Chopin D; Thiery JP; Radvanyi F
Oncogene; 1999 Dec; 18(51):7234-43. PubMed ID: 10602477
[TBL] [Abstract][Full Text] [Related]
10. The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling.
Mai S; Wei K; Flenniken A; Adamson SL; Rossant J; Aubin JE; Gong SG
Dev Dyn; 2010 Jun; 239(6):1888-900. PubMed ID: 20503384
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
[TBL] [Abstract][Full Text] [Related]
12. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.
Moffa AB; Tannheimer SL; Ethier SP
Mol Cancer Res; 2004 Nov; 2(11):643-52. PubMed ID: 15561780
[TBL] [Abstract][Full Text] [Related]
13. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice.
Baraniak AP; Chen JR; Garcia-Blanco MA
Mol Cell Biol; 2006 Feb; 26(4):1209-22. PubMed ID: 16449636
[TBL] [Abstract][Full Text] [Related]
14. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
15. The roles of FGF signaling in germ cell migration in the mouse.
Takeuchi Y; Molyneaux K; Runyan C; Schaible K; Wylie C
Development; 2005 Dec; 132(24):5399-409. PubMed ID: 16291796
[TBL] [Abstract][Full Text] [Related]
16. Exon III splicing of fibroblast growth factor receptor 1 is modulated by growth factors and cyclin D1.
Chen G; Wang J; Liu Z; Kornmann M
Pancreas; 2008 Aug; 37(2):159-64. PubMed ID: 18665077
[TBL] [Abstract][Full Text] [Related]
17. Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition.
Ranieri D; Rosato B; Nanni M; Magenta A; Belleudi F; Torrisi MR
Oncotarget; 2016 Feb; 7(5):5440-60. PubMed ID: 26713601
[TBL] [Abstract][Full Text] [Related]
18. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
Ittman M; Mansukhani A
J Urol; 1997 Jan; 157(1):351-6. PubMed ID: 8976296
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4.
Revest JM; Spencer-Dene B; Kerr K; De Moerlooze L; Rosewell I; Dickson C
Dev Biol; 2001 Mar; 231(1):47-62. PubMed ID: 11180951
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium.
Murgue B; Tsunekawa S; Rosenberg I; deBeaumont M; Podolsky DK
Cancer Res; 1994 Oct; 54(19):5206-11. PubMed ID: 7923141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
